• Connect with us
    • Information
      • About Us
      • Contact Us
      • Careers
      • Partnerships
      • Advertise With Us
      • Authors
      • Browse Topics
      • Events
      • Disclaimer
      • Privacy Policy
    • Australia
      North America
      World
    Login
    Investing News NetworkYour trusted source for investing success
    • North America
      Australia
      World
    • My INN
    Videos
    Companies
    Press Releases
    Private Placements
    SUBSCRIBE
    • Reports & Guides
      • Market Outlook Reports
      • Investing Guides
    • Button
    Resource
    • Precious Metals
    • Battery Metals
    • Base Metals
    • Energy
    • Critical Metals
    Tech
    Life Science
    Genetics Market
    Genetics News
    Genetics Stocks
    • Genetics Market
    • Genetics News
    • Genetics Stocks

    Veritas Genetics Launches $999 Whole Genome And Sets New Standard For Genetic Testing

    Vivien Diniz
    Mar. 03, 2016 09:13AM PST
    Genetics Investing

    Veritas Genetics introduced Veritas myGenome, the world’s first whole genome for less than $1,000, including interpretation and genetic counseling. Veritas Genetics first broke the $1,000 genome barrier in 2015 when it made whole genome sequencing available to nearly 5,000 participants in the Personal Genome Project (PGP) at Harvard Medical School.

    Veritas Genetics introduced  Veritas myGenome, the world’s first whole genome for less than $1,000, including interpretation and genetic counseling. Veritas Genetics first broke the $1,000 genome barrier in 2015 when it made whole genome sequencing available to nearly 5,000 participants in the Personal Genome Project (PGP) at Harvard Medical School.
    According to the news:

    Veritas Genetics is building a platform that will make it easy for its customers and their healthcare providers to use genetic information throughout their lives, including:

    • A secure digital report and app to easily refer to and interact with results.

    • Access to their genome for additional interpretation as health needs evolve and science advances.

    • On-demand additional genetic counseling via video conferencing.

    • Lifestyle-relevant genetic information that can be shared with non-clinical service providers such as fitness coaches and nutritionists.

    • Access to physicians at Massachusetts General Hospital, Dana Farber Cancer Institute, Boston Children’s Hospital, Mayo Clinic, and others for clinical opinions and clinical follow-up care through Veritas Genetics’ partnership with WorldCare International and WorldCare Consortium®.

    • Integration of other “omics” data sets on a single platform.

    Mirza Cifric, CEO and co-founder commented:

    The whole genome is the new standard. At this price point, there is no reason to use anything but the whole genome, especially for any tests that are close to or more than the price of our whole genome. The whole genome is the foundation of precision medicine and a lifetime resource to maximize quality of life and longevity.

    Click here to view the full press release. 

    mayo clinicprecision medicine
    The Conversation (0)

    Go Deeper

    AI Powered
    Senior woman doing exercises alongside closeup of DNA.

    5 US Longevity and Anti-aging Stocks to Watch in 2025

    hand holding dna helix

    How to Invest in Genetics

    Latest News

    Outlook Reports

    Resource
    • Precious Metals
      • Gold
      • Silver
    • Battery Metals
      • Lithium
      • Cobalt
      • Graphite
    • Energy
      • Uranium
      • Oil and Gas
    • Base Metals
      • Copper
      • Nickel
      • Zinc
    • Critical Metals
      • Rare Earths
    • Industrial Metals
    • Agriculture
    Tech
      • Artificial Intelligence
      • Cybersecurity
      • Gaming
      • Cleantech
      • Emerging Tech
    Life Science
      • Biotech
      • Cannabis
      • Psychedelics
      • Pharmaceuticals

    Featured Stocks

    More featured stocks

    Browse Companies

    Resource
    • Precious Metals
    • Battery Metals
    • Energy
    • Base Metals
    • Critical Metals
    Tech
    Life Science
    MARKETS
    COMMODITIES
    CURRENCIES
    ×